|
White Paper on The Future of Medical Science
The Chairman of the KIN Consortium would like to share his analysis of Stem Cell Technologies www.stemcell.com . A center for trading clones of Stems, which will be called the International
Stem Cell Exchange (ISCE). This centralized exchange will be a data center that expedites
delivery of product, accuracy of product description, accurate price, & accounting for transactions. By default the ISCE will set the standard of excellence for the trading of Stems from one research center to another.
The Chairman likes
to draw comparisons between the ISCE and the NASDAQ, which would put the Stem cell research center in the
position of an Investment Bank. Subsequently, every batch of new stems is considered
as an IPO (Initial Public Offering) that will trade on the ISCE. The future of medicine is allowing
antibodies to be bought & sold directly by Biotechnology firms or hematoligists all around the world. Thus allowing
for faster production & refinement of medicine. This technology screens out side effects
faster than before thus ramping up the growth rate of new medicine.
The growth of the ISCE's Business Model is positively
correlated with the size of the market in terms of the demand for new antibodies & public awareness of the benefits of stem cell research.
Target Market The
Exchange
(ISCE)
1) World Health Organization 1) Bulletin board
2) New Stem Cell Research
of available
Centers. clone of
Stems.
3) Hematologists & Blood
2) Full description
Banks
of Isotype, Antigen,
Quantity, Age, etc.
4) CDC Centers.
5) Genetists.
3) Expedited state of
the art delivery system.
4) Accounting
for
transactions.
5) Order Entry system
for licensed
(ISCE)
buyers & sellers.
For the highlights of the international promotional
campaign on Cloning Lymphocytes subscribe to "The Natto Perspective" an affilliate of The
KIN Consortium.
Hire KIN Consulting and Research Services for details on the
business model of the ISCE.
Signed,
Telephone and Voicemail Number: 1(413)-370-2346
Fax Number: 1(610)-300-5883
International promotional campaign for the concept of cloning lymphocytes.
Please subscribe now!
=================================================================
Disclaimer of Warranty and Limitation of Liability
The
information, products and services on this web site or letter are provided on an "AS IS," "WHERE IS" and "WHERE AVAILABLE"
basis. The KIN Consortium does not warrant the information or services provided herein or your
use of this web site generally, either expressly or impliedly, for any particular purpose and expressly disclaims any implied
warranties, including but not limited to, warranties of title, non-infringement, merchantability or fitness for a particular
purpose. The KIN Consortium will not be responsible for any loss or damage that could result from interception
by third parties of any information or services made available to you via this web site. Although the information provided
to you on this web site is obtained or compiled from sources we believe to be reliable, The KIN Consortium
cannot and does not guarantee the accuracy, validity, timeliness or completeness of any information or data made available
to you for any particular purpose. Neither The KIN Consortium , nor any of its affiliates, directors,
officers or employees, nor any third party vendor, will be liable or have any responsibility of any kind for any loss or damage
that you incur in the event of any failure or interruption of this web site, or resulting from the act or omission of any
other party involved in making this web site, the data contained herein or the products or services offered on this web site
available to you, or from any other cause relating to your access to, inability to access, or use of the web site or these
materials, whether or not the circumstances giving rise to such cause may have been within the control of The KIN
Consortium or of any vendor providing software or services. In no event will The KIN Consortium
or any such parties be liable to you, whether in contract or tort, for any direct, special, indirect, consequential or incidental
damages or any other damages of any kind even if The KIN Consortium or any other such party has been
advised of the possibility thereof. This limitation on liability includes, but is not limited to, the transmission of any
viruses which may infect a user's equipment, failure of mechanical or electronic equipment or communication lines, telephone
or other interconnect problems (e.g., you cannot access your internet service provider), unauthorized access, theft, operator
errors, strikes or other labor problems. The KIN Consortium cannot and does not guarantee continuous,
uninterrupted or secure access to the web site.
Proprietary Rights
All right, title and interest
in this web site and any content contained herein is the exclusive property of The KIN Consortium ,
except as otherwise stated. Unless otherwise specified, this web site is for your personal and non-commercial use only and
you may print, copy and download any information or portion of this web site for your personal use only. You may not modify,
copy, distribute, transmit, display, perform, reproduce, publish, license, frame, create derivative works from, transfer,
or otherwise use in any other way for commercial or public purposes in whole or in part any information, software, products
or services obtained from this web site, except for the purposes expressly provided herein, without The KIN Consortium's prior
written approval. If you copy or download any information or software from this web site, you agree that you will not remove
or obscure any copyright or other notices or legends contained in any such information.
The KIN Consortium and
other trademarks and service marks referenced herein are trademarks and service marks of The KIN Consortium .
The names of other companies and third-party products or services mentioned herein may be the trademarks or service marks
of their respective owners. You are prohibited from using any marks for any purpose including, but not limited to use as metatags
on other pages or sites on the World Wide Web without the written permission of The KIN Consortium
or such third party, which may own the marks.
Pursuant to Section 512(c)(2) of the Copyright Act, The KIN
Consortium designates the following agent to receive notifications of claimed infringement: Khalid I Natto,
The KIN Consortium , Email: kalnatto2000@yahoo.com Website: http://khalidnatto.tripod.com
Use of Links
This web site contains links
to third party web sites. These links are provided only as a convenience. The inclusion of any link is not and does not imply
an affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring by The KIN Consortium
of any information contained in any third party web site. In no event shall The KIN Consortium be responsible
for the information contained on that site or your use of or inability to use such site. You should also be aware that the
terms and conditions of such site and the site's privacy policy may be different from those applicable to your use of this
web site.
|
